Table 1.
Prevalence of suboptimal cholesterol concentrations, eligibility for treatment, treated and controlled hypercholesterolaemia in men and women by 10-year age category, weighted by the age and gender distribution of the general Dutch population in 1992 and corrected for intra-person variability.
| Respondents | Suboptimal cholesterol concentrations (Tc > 5 mmol l−1) | Eligible for treatment (including those treated)* | Treated | Controlled** | |
|---|---|---|---|---|---|
| Overall | 63 423 | 40 064 (56.8%) | 2719 (5.5%) | 430 (16.3%) | 83 (19.6%/3.2%) |
| Men | |||||
| 20–29 years | 5 107 | 1 471 (28.8%) | 6 (0.4%) | 4 (66.7%) | 1 (25.0%/16.7%) |
| 30–39 years | 7 476 | 4 271 (57.1%) | 65 (1.5%) | 16 (24.6%) | 1 (6.2%/1.5%) |
| 40–49 years | 8 693 | 6 705 (77.1%) | 369 (5.5%) | 83 (22.5%) | 15 (18.1%/4.1%) |
| 50–59 years | 8 341 | 7 089 (85.0%) | 1558 (22.0%) | 156 (10.0%) | 39 (25.0%/2.5%) |
| 20–59 years | 29 617 | 19 536 (58.8%) | 1998 (7.9%) | 259 (14.1%) | 56 (20.7%/2.9%) |
| Women | |||||
| 20–29 years | 6 248 | 2 251 (36.0%) | 6 (0.3%) | 1 (16.7%) | 1 (100%/16.7%) |
| 30–39 years | 8 484 | 3 732 (44.0%) | 48 (1.3%) | 7 (14.6%) | 2 (28.6%/4.2%) |
| 40–49 years | 9 734 | 6 328 (65.0%) | 136 (2.1%) | 29 (21.3%) | 8 (27.6%/5.9%) |
| 50–59 years | 9 340 | 8 217 (88.0%) | 531 (6.5%) | 134 (25.2%) | 16 (11.9%/3.0%) |
| 20–59 years | 33 806 | 20 528 (54.8%) | 721 (2.8%) | 171 (23.1%) | 27 (17.4%/4.0%) |
*
based on the Dutch Consensus Cholesterol
**
% of those treated and percentage of those eligible for treatment, respectively.